Kineta is an emerging and sustainable biotech company that fills a void in the biopharmaceutical industry by efficiently advancing therapies from discovery to clinical proof of concept. We actively collaborate with a broad array of private, government and industry partners to advance our innovative research. Our unique funding model was designed to mitigate risk and may provide an attractive and earlier return for investors. Kineta has established and is expanding on a diverse pipeline of novel life improving therapies that address critical unmet patient needs.

Kineta, Inc. was founded in 2008 by Drs. Shawn Iadonato and Charles Magness. The company is based in Seattle, WA in close proximity to numerous research organizations, academic centers and other biotech companies. Seattle Business Magazine named Kineta the winner in the field of biopharmaceutical achievement for its innovative approach to drug development and investor-friendly business plan in March 2014.